Related Experiment Videos

Aberrant phagocyte function in Shwachman syndrome

H Repo1, E Savilahti, M Leirisalo-Repo

  • 1Department of Bacteriology and Immunology, University of Helsinki, Finland.

Insights

Shwachman syndrome patients exhibit abnormal polymorphonuclear leucocyte (PMN) function. Their PMN show increased chemiluminescence and impaired chemotaxis, suggesting separate defects in PMN and monocytes (MO).

Area of Science:

  • Immunology
  • Hematology
  • Genetic Disorders

Background:

  • Polymorphonuclear leucocytes (PMN) from Shwachman syndrome patients demonstrate reduced in vitro mobility.
  • Understanding the specific cellular defects in Shwachman syndrome is crucial for diagnosis and treatment.

Purpose of the Study:

  • To investigate the chemotaxis and chemiluminescence responses of purified PMN and monocytes (MO) in Shwachman syndrome patients.
  • To elucidate the cellular basis of impaired immune cell function in Shwachman syndrome.

Main Methods:

  • Purified PMN and MO from seven Shwachman syndrome patients were analyzed.
  • Chemotaxis assays (membrane filter and agarose) and chemiluminescence assays were performed.

Main Results:

  • Patients' PMN exhibited significantly increased chemiluminescence, suggesting auto-oxidation.
  • Chemotaxis of purified PMN was impaired under agarose but not membrane filter assays when remixed with autologous mononuclear cells or MO.
  • Both chemotaxis and chemiluminescence responses of patients' MO were depressed, indicating distinct defects in PMN and MO.

Conclusions:

  • Impaired PMN mobility in Shwachman syndrome may stem from auto-oxidation.
  • The agarose assay is more sensitive for detecting impaired PMN chemotaxis than the filter assay.
  • Shwachman syndrome involves separate functional defects in both PMN and MO.

Related Concept Videos